AGEN

Agenus Inc. - Common Stock (AGEN)

About Agenus Inc. - Common Stock (AGEN)

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Details

Daily high

$4.98

Daily low

$4.50

Price at open

$4.57

52 Week High

$18.74

52 Week Low

$1.38

Market cap

131.1M

Dividend yield

0.00%

Volume

1.6M

Avg. volume

1.7M

P/E ratio

-.55

Agenus Inc. - Common Stock News